感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2015 NICE指南：抗菌药物管理（NG.15）

2015-08-18 NICE官网

抗菌药物

2015年8月，英国国家卫生与临床优化研究所 (NICE)发布了有效应用抗菌药的系统和过程指南。针对所有的医疗相关人员：健康社会保健医师、供应商、普通使用者、旨在帮助全社会更有效的使用抗菌药物。

中文标题：

2015 NICE指南：抗菌药物管理（NG.15）

英文标题：

Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use

发布机构：

发布日期：

2015-08-18

简要介绍：

2015年8月，英国国家卫生与临床优化研究所 (NICE)发布了有效应用抗菌药的系统和过程指南。针对所有的医疗相关人员：健康社会保健医师、供应商、普通使用者、旨在帮助全社会更有效的使用抗菌药物。

拓展指南：与抗菌药物相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2015 NICE指南：抗菌药物管理（NG.15）)] GetToolGuiderByIdResponse(projectId=1, id=53a571c00130601c, title=2015 NICE指南：抗菌药物管理（NG.15）, enTitle=Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use, guiderFrom=NICE官网, authorId=null, author=, summary=2015年8月，英国国家卫生与临床优化研究所 (NICE)发布了有效应用抗菌药的系统和过程指南。针对所有的医疗相关人员：健康社会保健医师、供应商、普通使用者、旨在帮助全社会更有效的使用抗菌药物。, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Aug 18 00:00:00 CST 2015, originalUrl=, linkOutUrl=, content=2015年8月，英国国家卫生与临床优化研究所 (NICE)发布了有效应用抗菌药的系统和过程指南。针对所有的医疗相关人员：健康社会保健医师、供应商、普通使用者、旨在帮助全社会更有效的使用抗菌药物。<br> <br> 拓展指南：<strong>与<font color="red">抗菌药物</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=6d11e1c00125312b" title="2016 BSAC/EWMA意见书：创伤护理中抗菌药物管理" target="_blank">2016 BSAC/EWMA意见书：创伤护理中抗菌药物管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=584131c00119a6b7" title="中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南（2016年版）" target="_blank">中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南（2016年版）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=bac7c1c0011e0184" title="尿路感染诊断与治疗中国专家共识(2015版)——尿路感染抗菌药物选择策略及特殊类型尿路感染的治疗建议" target="_blank">尿路感染诊断与治疗中国专家共识(2015版)——尿路感染抗菌药物选择策略及特殊类型尿路感染的治疗建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3669f1c001038abe" title="抗菌药物敏感性试验执行标准; 第二十四版资料增刊" target="_blank">抗菌药物敏感性试验执行标准; 第二十四版资料增刊</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=978bb1c00103826e" title="抗菌药物临床应用指导原则（征求意见稿）（2014版）" target="_blank">抗菌药物临床应用指导原则（征求意见稿）（2014版）</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E6%8A%97%E8%8F%8C%E8%8D%AF%E7%89%A9" target="_blank">有关抗菌药物更多指南</a></ul>, tagList=[TagDto(tagId=5642, tagName=抗菌药物)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5220, appHits=197, showAppHits=0, pcHits=3912, showPcHits=1542, likes=152, shares=6, comments=4, approvalStatus=1, publishedTime=Wed Oct 12 13:37:28 CST 2016, publishedTimeString=2015-08-18, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Wed Oct 12 13:37:28 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:52:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2015 NICE指南：抗菌药物管理（NG.15）)])
2015 NICE指南：抗菌药物管理（NG.15）
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=147984, encodeId=7a8914e98434, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Fri Oct 14 00:32:53 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147649, encodeId=832614e64908, content=没有翻译版本？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e0c1940872, createdName=1e0ef473m06(暂无匿称), createdTime=Thu Oct 13 13:47:32 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147046, encodeId=c62614e046c2, content=好东西，分享一个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Oct 12 16:56:34 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147045, encodeId=372714e0459c, content=居然没人评论, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Oct 12 16:56:20 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-14 后宫三千

    好东西

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=147984, encodeId=7a8914e98434, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Fri Oct 14 00:32:53 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147649, encodeId=832614e64908, content=没有翻译版本？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e0c1940872, createdName=1e0ef473m06(暂无匿称), createdTime=Thu Oct 13 13:47:32 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147046, encodeId=c62614e046c2, content=好东西，分享一个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Oct 12 16:56:34 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147045, encodeId=372714e0459c, content=居然没人评论, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Oct 12 16:56:20 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-13 1e0ef473m06(暂无匿称)

    没有翻译版本？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=147984, encodeId=7a8914e98434, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Fri Oct 14 00:32:53 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147649, encodeId=832614e64908, content=没有翻译版本？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e0c1940872, createdName=1e0ef473m06(暂无匿称), createdTime=Thu Oct 13 13:47:32 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147046, encodeId=c62614e046c2, content=好东西，分享一个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Oct 12 16:56:34 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147045, encodeId=372714e0459c, content=居然没人评论, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Oct 12 16:56:20 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-12 1e128d2fm65(暂无匿称)

    好东西，分享一个

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=147984, encodeId=7a8914e98434, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Fri Oct 14 00:32:53 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147649, encodeId=832614e64908, content=没有翻译版本？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e0c1940872, createdName=1e0ef473m06(暂无匿称), createdTime=Thu Oct 13 13:47:32 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147046, encodeId=c62614e046c2, content=好东西，分享一个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Oct 12 16:56:34 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147045, encodeId=372714e0459c, content=居然没人评论, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Oct 12 16:56:20 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-12 1e128d2fm65(暂无匿称)

    居然没人评论

    0

相关指南

2016 BSAC/EWMA意见书：创伤护理中抗菌药物管理

英国抗菌化疗学会(BSAC,British Society for Antimicrobial Chemotherapy) · 2016-07-25